Cold agglutinin disease (CAD) is marked by the destruction of red blood cells, cells essential to transporting oxygen to tissues. Their loss can lead to symptoms that include joint pain, fatigue, and cardiac issues. Your doctor may recommend a blood transfusion to help ease these symptoms. Here are answers to some frequently…
FAQs
Cold agglutinin disease (CAD) is a rare disorder in which the immune system produces autoantibodies that attack the body’s own red blood cells when exposed to cold temperatures. Plasmapheresis can provide temporary relief of symptoms by removing autoantibodies from the blood. Here Following are a few frequently asked questions…
A leading treatment for cold agglutinin disease (CAD) is rituximab. Following  are answers to some questions you might have before you decide to start treatment. How does rituximab work? CAD is caused by immune cells in the body called B-cells producing antibodies that bind to red…
A diagnosis of cold agglutinin disease (CAD) can be challenging for patients and their families. As a rare disease, it can be difficult to find information about CAD or its treatments. To help, below are answers to some frequently asked questions about CAD. What is CAD? CAD is a…
Recent Posts
- Blood stem cell transplant complicated by temporary CAD in donor: Case report
- After a trip to the ER, I’m figuring out how to strengthen my immune system
- Study finds inherited thrombophilia screening not needed in AIHA
- For US woman, CAD exacerbates iron disorder, leading to liver damage
- Post-exertional malaise leads to a cycle of crashes and comebacks
- Enjaymo provides lasting CAD control even with fewer doses: Study
- Being vigilant during transfusions brings me a vital victory
- Rituximab helps treat CAD linked to long-term immunosuppression: Case
- With my health from CAD steadily declining, I call in the cavalry, part 3
- Rituximab effective in rare dual autoimmune blood disorder case